These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11144309)

  • 41. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.
    de Hoog M; van Zanten BA; Hop WC; Overbosch E; Weisglas-Kuperus N; van den Anker JN
    J Pediatr; 2003 Jan; 142(1):41-6. PubMed ID: 12520253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.
    Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F
    J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit.
    Vella-Brincat JW; Begg EJ; Robertshawe BJ; Lynn AM; Borrie TL; Darlow BA
    Neonatology; 2011; 100(2):186-93. PubMed ID: 21455009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns.
    Fonzo-Christe C; Guignard B; Zaugg C; Coehlo A; Posfay-Barbe KM; Gervaix A; Desmeules J; Rollason V; Combescure C; Corbelli R; Rimensberger P; Pfister R; Bonnabry P
    Ther Drug Monit; 2014 Oct; 36(5):656-62. PubMed ID: 24690586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
    J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates.
    Begg EJ; Vella-Brincat JW; Robertshawe B; McMurtrie MJ; Kirkpatrick CM; Darlow B
    J Antimicrob Chemother; 2009 May; 63(5):1043-9. PubMed ID: 19299469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.
    Auriti C; Ravà L; Di Ciommo V; Ronchetti MP; Orzalesi M
    J Hosp Infect; 2005 Apr; 59(4):292-8. PubMed ID: 15749316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended-interval gentamicin administration in malnourished children.
    Khan AM; Ahmed T; Alam NH; Chowdhury AK; Fuchs GJ
    J Trop Pediatr; 2006 Jun; 52(3):179-84. PubMed ID: 16126804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
    Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
    Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of aminoglycosides in the intensive care unit.
    Radigan EA; Gilchrist NA; Miller MA
    J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamic target attainment with high-dose extended-interval tobramycin therapy in patients with cystic fibrosis.
    DeGrado JR; Cios D; Greenwood BC; Kubiak DW; Szumita PM
    J Chemother; 2014 Apr; 26(2):101-4. PubMed ID: 24090527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
    Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
    Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of six extended-interval gentamicin dosing regimens in premature and full-term neonates.
    Fullas F; Padomek MT; Thieman CJ; Van Gorp AE
    Am J Health Syst Pharm; 2011 Jan; 68(1):52-6. PubMed ID: 21164066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gentamicin dosing recommendations.
    Noerr B
    Neonatal Netw; 2000 Jun; 19(4):81-6. PubMed ID: 11949106
    [No Abstract]   [Full Text] [Related]  

  • 58. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
    Miller MM; Burton ME; Johnson PN; Miller JL
    Am J Health Syst Pharm; 2014 Dec; 71(24):2108-9. PubMed ID: 25465576
    [No Abstract]   [Full Text] [Related]  

  • 59. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aminoglycoside dosage in pediatric patients:considerations regarding pharmacokinetic-based dose adjustment in patients requiring high versus low dose therapy.
    Leff RD; Roberts RJ
    Dev Pharmacol Ther; 1981; 3(4):242-50. PubMed ID: 7344881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.